BDO Wealth Advisors’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5
Closed -$51 1084
2022
Q4
$51 Hold
5
﹤0.01% 1004
2022
Q3
$0 Hold
5
﹤0.01% 1102
2022
Q2
$0 Hold
5
﹤0.01% 1091
2022
Q1
$0 Hold
5
﹤0.01% 1113
2021
Q4
$1K Sell
5
-50
-91% -$8.59K ﹤0.01% 1036
2021
Q3
$11K Buy
55
+25
+83% +$5.51K ﹤0.01% 710
2021
Q2
$6K Hold
30
﹤0.01% 842
2021
Q1
$5K Sell
30
-165
-85% -$32.9K ﹤0.01% 846
2020
Q4
$22K Buy
+195
New +$20.7K ﹤0.01% 456

Other funds holding NVAX

BDO Wealth Advisors's NVAX Position: Q1 2023 in Review

BDO Wealth Advisors sold out of Novavax (NVAX) in Q1 2023, closing a stake of 5 shares — an estimated $51 sold.

BDO Wealth Advisors first reported a position in NVAX in Q4 2020 and held it in 9 quarters. The position peaked at $22K in Q4 2020. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • BDO Wealth Advisors reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • BDO Wealth Advisors sold 5 Novavax shares in Q1 2023, an estimated $51.
  • BDO Wealth Advisors first reported a position in Novavax in Q4 2020 and held it in 9 quarters.
  • BDO Wealth Advisors's Novavax position peaked at $22K in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on BDO Wealth Advisors's 13F filing for Q1 2023, filed 9 May 2023.